Lupin Pushes Fed. Circ. To Reconsider Fortamet Injunction
Sciele Pharma Inc., a unit of Shionogi Pharma Inc., sued the generic-drug maker in January 2009 after Lupin submitted an abbreviated new drug application to the U.S. Food and Drug Administration to make a generic version of Fortamet, a blood glucose-regulating drug.
While Lupin argued that the...
To view the full article, register now.